Parametric Portfolio Associates’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-216,130
| Closed | -$11.3M | – | 4081 |
|
|
2020
Q3 | $11.3M | Sell |
216,130
-59,155
| -21% | -$2.45M | 0.01% | 1311 |
|
|
2020
Q2 | $9.16M | Buy |
275,285
+66,452
| +32% | +$2.12M | 0.01% | 1453 |
|
|
2020
Q1 | $5.68M | Buy |
208,833
+51,625
| +33% | +$1.44M | 0.01% | 1642 |
|
|
2019
Q4 | $3.1M | Buy |
157,208
+11,408
| +8% | +$182K | ﹤0.01% | 2394 |
|
|
2019
Q3 | $1.89M | Buy |
145,800
+34,580
| +31% | +$418K | ﹤0.01% | 2670 |
|
|
2019
Q2 | $1.39M | Sell |
111,220
-23,126
| -17% | -$307K | ﹤0.01% | 2882 |
|
|
2019
Q1 | $1.95M | Buy |
134,346
+44,464
| +49% | +$568K | ﹤0.01% | 2678 |
|
|
2018
Q4 | $992K | Buy |
89,882
+5,123
| +6% | +$71.3K | ﹤0.01% | 2983 |
|
|
2018
Q3 | $2.23M | Buy |
84,759
+423
| +0.5% | +$11.4K | ﹤0.01% | 2641 |
|
|
2018
Q2 | $1.73M | Buy |
84,336
+5,499
| +7% | +$118K | ﹤0.01% | 2773 |
|
|
2018
Q1 | $1.43M | Buy |
78,837
+10,653
| +16% | +$178K | ﹤0.01% | 2812 |
|
|
2017
Q4 | $951K | Sell |
68,184
-3,391
| -5% | -$45.8K | ﹤0.01% | 3043 |
|
|
2017
Q3 | $1.32M | Sell |
71,575
-4,191
| -6% | -$70.1K | ﹤0.01% | 2859 |
|
|
2017
Q2 | $1.28M | Buy |
75,766
+10,757
| +17% | +$164K | ﹤0.01% | 2834 |
|
|
2017
Q1 | $868K | Sell |
65,009
-1,227
| -2% | -$19.2K | ﹤0.01% | 2937 |
|
|
2016
Q4 | $997K | Buy |
66,236
+10,505
| +19% | +$139K | ﹤0.01% | 2828 |
|
|
2016
Q3 | $651K | Buy |
55,731
+7,527
| +16% | +$88.5K | ﹤0.01% | 3038 |
|
|
2016
Q2 | $521K | Buy |
48,204
+16,130
| +50% | +$166K | ﹤0.01% | 3173 |
|
|
2016
Q1 | $296K | Sell |
32,074
-3,869
| -11% | -$41.6K | ﹤0.01% | 3611 |
|
|
2015
Q4 | $533K | Buy |
35,943
+1,653
| +5% | +$27.7K | ﹤0.01% | 3204 |
|
|
2015
Q3 | $563K | Buy |
34,290
+11,172
| +48% | +$229K | ﹤0.01% | 2662 |
|
|
2015
Q2 | $527K | Buy |
23,118
+1,384
| +6% | +$27.6K | ﹤0.01% | 3244 |
|
|
2015
Q1 | $330K | Buy |
21,734
+277
| +1% | +$3.6K | ﹤0.01% | 3511 |
|
|
2014
Q4 | $258K | Buy |
21,457
+2,719
| +15% | +$31.1K | ﹤0.01% | 3660 |
|
|
2014
Q3 | $212K | Buy |
+18,738
| New | +$214K | ﹤0.01% | 3594 |
|
|
2014
Q2 | – | Sell |
-21,421
| Closed | -$250K | – | 3825 |
|
|
2014
Q1 | $250K | Sell |
21,421
-469
| -2% | -$7.94K | ﹤0.01% | 3537 |
|
|
2013
Q4 | $387K | Buy |
21,890
+2,940
| +16% | +$49.4K | ﹤0.01% | 3302 |
|
|
2013
Q3 | $273K | Buy |
18,950
+626
| +3% | +$9.58K | ﹤0.01% | 3445 |
|
|
2013
Q2 | $276K | Buy |
+18,324
| New | +$242K | ﹤0.01% | 3313 |
|
Parametric Portfolio Associates's MNTA Position: Q4 2020 in Review
Parametric Portfolio Associates sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 216,130 shares — an estimated $11.3M sold.
Parametric Portfolio Associates first reported a position in MNTA in Q2 2013 and held it in 29 quarters. The position peaked at $11.3M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Parametric Portfolio Associates reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Parametric Portfolio Associates sold 216,130 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $11.3M.
- Parametric Portfolio Associates first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 29 quarters.
- Parametric Portfolio Associates's Momenta Pharmaceuticals, Inc. position peaked at $11.3M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Parametric Portfolio Associates's 13F filing for Q4 2020, filed 12 Feb 2021.